Fatores que interferem na produção de antígenos de Histoplasma capsulatum
PDF (English)

Palavras-chave

Histoplasma
Histoplasmose
Variação Fenotípica
Antígenos
Terapia Antirretroviral

Como Citar

1.
Santos de Freitas-Xavier R, Alves Feitosa Maciel I, Teixeira de Freitas VL, Vicentini AP. Fatores que interferem na produção de antígenos de Histoplasma capsulatum. Rev Inst Adolfo Lutz [Internet]. 8º de novembro de 2023 [citado 25º de abril de 2024];82:1-14,e39242. Disponível em: https://periodicos.saude.sp.gov.br/RIAL/article/view/39242

Resumo

Histoplasma capsulatum causa micose sistêmica endêmica que depende da suscetibilidade do hospedeiro, da virulência fúngica e de  fatores associados ao processo infeccioso. Avaliamos a possível interferência do fenótipo de 12 amostras de H. capsulatum isolados de pacientes HIV positivos e negativos na obtenção de antígenos, visando o diagnóstico sorológico por meio do reconhecimento gênero-específico das frações H e M. Os antígenos foram avaliados por imunodifusão dupla, frente a  anticorpo policlonal anti-antígeno de H. capsulatum e  frente a amostras de soro de pacientes com histoplasmose. A avaliação fenotípica revelou diferenças, não só na identificação do agente fúngico, mas também na expressão dos antígenos H e M, considerados marcadores sorológicos da doença, associados à pigmentação e produção de conídios. Verificou-se que preparações antigênicas obtidas de H. capsulatum isoladas de pacientes HIV positivos podem ter capacidade antigênica satisfatória. O estado imunológico do paciente parece não interferir na expressão de proteínas antigênicas secretadas por H. capsulatum. No entanto, sugerimos que o uso prolongado de antirretrovirais e/ou esteróides pode causar alterações fenotípicas importantes. Verificou-se que algumas amostras fúngicas isoladas de pacientes com longo histórico de uso de imunossupressores produziram elementos celulares atípicos e baixa reatividade sorológica contra as frações H e M de H. capsulatum.

https://doi.org/10.53393/rial.2023.82.39242
PDF (English)

Referências

1. Wheat LJ, Azar MM, Bahr NC, Spec A, Relich RF, Hage C. Histoplasmosis. Infect Dis Clin North Am. 2016;30(1):207-27. https://doi.org/10.1016/j.idc.2015.10.009

2 Azar MM, Loyd JL, Relich RF, Wheat LJ, Hage CA. Current concepts in the epidemiology, diagnosis, and management of histoplasmosis syndromes. Semin Respir Crit Care Med. 2020;41(1):13-30. https://doi.org/10.1055/s-0039-1698429

3 Sahaza JH, Pérez-Torres A, Zenteno E, Taylor ML. Usefulness of the murine model to study the immune response against Histoplasma capsulatum infection. Comp Immunol Microbiol Infect Dis. 2014;37(3):143-52. https://doi.org/10.1016/j.cimid.2014.03.002

4 Armstrong-James D, Meintjes G, Brown GD. A neglected epidemic: Fungal infections in HIV/AIDS. Trends Microbiol. 2014;22(3):120-7. http://dx.doi.org/10.1016/j.tim.2014.01.001

5 Almeida MA, Almeida-Silva F, Guimarães AJ, Almeida-Paes R, Zancopé-Oliveira RM. The occurrence of histoplasmosis in Brazil: A systematic review. Int J Infect Dis. 2019;86:147-56. https://doi.org/10.1016/j.ijid.2019.07.009

6 Adenis AA, Aznar C, Couppié P. Histoplasmosis in HIV-infected patients: A review of new developments and remaining gaps. Curr Trop Med Rep. 2014;1:119-28. https://doi.org/10.1007/s40475-014-0017-8

7 Franklin AD, Larson L, Rauseo AM, Rutjanawech S, Hendrix MJ, Powderly WG et al. A comparison of presentations and outcomes of histoplasmosis across patients with varying immune status. Med Mycol. 2021;59(6):624-33. https://doi.org/10.1093/mmy/myaa112

8 Arango-Bustamante K, Restrepo A, Cano LE, Bedout C, Tobón AM, González A. Diagnostic value of culture and serological tests in the diagnosis of histoplasmosis in HIV and non-HIV Colombian patients. Am J Trop Med Hyg. 2013;89(5):937-42. https://doi.org/10.4269/ajtmh.13-0117

9 Azar MM, Hage CA. Laboratory diagnostics for histoplasmosis. J Clin Microbiol. 201;55(6):1612-20. https://doi.org/10.1128/JCM.02430-16

10 Caceres DH, Chiller T, Lindsley MD. Immunodiagnostic assays for the investigation of fungal outbreaks. Mycopathologia. 2020;185(5):867-80. https://doi.org/10.1007/s11046-020-00452-x

11 Toscanini MA, Nusblat AD, Cuestas ML. Diagnosis of histoplasmosis: current status and perspectives. Appl Microbiol Biotechnol. 2021;105:1837-59. https://doi.org/10.1007/s00253-021-11170-9

12 Kaufman L, Standard P. Improved version of the exoantigen test for identification of Coccidioides immitis and Histoplasma capsulatum cultures. J Clin Microbiol. 1978;8(1):42-5. https://doi.org/10.1128/jcm.8.1.42-45.1978

13 Kaufman L, Standard P. Immuno-identification of cultures of fungi pathogenic to man. Curr Microbiol. 1978:1:135-40. https://doi.org/10.1007/BF02601665

14 Dantas KC, Freitas RS, Silva MV, Criado PR, Luiz OC, Vicentini AP. Comparison of diagnostic methods to detect Histoplasma capsulatum in serum and blood samples from AIDS patients. PLoS One. 2018;13(1):e0190408. https://doi.org/10.1371/journal.pone.0190408

15 Riddell RW. Permanent stained mycological preparations obtained by slide culture. Mycologia. 1950;42(2):265-70. https://doi.org/10.2307/3755439

16 Freitas RS, Kamikawa CM, Vicentini AP. Fast protocol for the production of Histoplasma capsulatum antigens for antibody detection in the immunodiagnosis of histoplasmosis. Rev Iberoam Micol. 2018:35(1):27-31. https://doi.org/10.1016/j.riam.2017.04.004

17 Freitas RS, Carvalho-Vivi JO, Zamboni IM, Assis CM, Costa-Martins JE, Vicentini-Moreira AP. The importance of serological assays in diagnosing acute pulmonary histoplasmosis. J Venom Anim Toxins Incl Trop Dis. 2009;15(2):278-88. https://doi.org/10.1590/S167891992009000200010

18 Mckinney MM, Parkinson A. A simple non-chromatographic procedureto purify immunoglobulins from serum and ascites fluids. J immunol Meth. 1987;96(2):271-8. https://doi.org/10.1016/0022-1759(87)90324-3

19. Hussain K, Malavia D, Johnson EM, Littlechild J, Winlove CP, Vollmer F et al. Biosensors and diagnostics for fungal detection. J Fungi. 2020;6(4):349. https://doi.org/10.3390/jof6040349

20 Domer JE. Monosaccharide and chitin content of cell walls of Histoplasma capsulatum and Blastomyces dermatitidis. J Bacteriol. 1971;107(3):870-7. https://doi.org/10.1128/jb.107.3.870-877.1971

21 Gorocica P, Taylor ML, Alvarado-Vásquez N, Pérez-Torres A, Lascurain R, Zenteno E. The interaction between Histoplasma capsulatum cell wall carbohydrates and host components: relevance in the immunomodulatory role of histoplasmosis. Mem Inst Oswaldo Cruz. 2009;104(3):492-6. https://doi.org/10.1590/s0074-02762009000300016

22 Kanetsuna F, Carbonell LM, Azuma I, Yamamura Y. Biochemical studies on the thermal dimorphism of Paracoccidioides brasiliensis. J Bacteriol. 1972;110(1):208-18. https://doi.org/10.1128/jb.110.1.208-218.1972

23 Kanetsuna F, Carbonell LM, Gil F, Azuma I. Chemical and ultrastructural studies on the cell walls of the yeast like and mycelial forms of Histoplasma capsulatum. Mycopathol Mycol Appl. 1974;54(1):1-13. https://doi.org/10.1007/BF02055967

24 Kanetsuna F. Ultrastructural studies on the dimorphism of Paracoccidioides brasiliensis, Blastomyces dermatitidis and Histoplasma capsulatum Sabouraudia. 1981;19(4):275-86. https://doi.org/10.1080/00362178185380451

25 Klimpel KR, Goldman WE. Cell walls from avirulent variants of Histoplasma capsulatum lack alpha-(1,3)-glucan. Infect Immun. 1988;56(11):2997-3000. https://doi.org/10.1128/iai.56.11.2997-3000.1988

26 Rappleye CA, Engle JT, Goldman WE. RNA interference in Histoplasma capsulatum demonstrates a role for α-(1,3)-glucan in virulence. Mol Microbiol. 2004;53(1):153-65. https://doi.org/10.1111/j.1365-2958.2004.04131.x

27 Ehrhard HB, Pine L. Factor influencing the production of H and M antigens by Histoplasma capsulatum: Development and evaluation of shake culture procedure. Appl Microbiol. 1972;23(2):236-49. https://doi.org/10.1128/am.23.2.236-249.1972

28 Berliner MD. Primary subcultures of Histoplasma capsulatum: I. Macro and micromorphology of the mycelial phase. Sabouraudia. 1968;6(2):111-8. https://doi.org/10.1080/00362176885190211

29 Borok R. The mycelial status and reversibility in Histoplasma capsulatum. Sabouraudia. 1980;18(4):249-53. https://doi.org/10.1080/00362178085380431

30 Freitas RS, Neves PS, Charbel CE, Criado PR, Nunes RS, Santos-Filho AM et al. Investigation of superficial mycosis in cutaneous allergy patients using topical or systemic corticosteroids. Int J Dermatol. 2017;56(10):e194-e198. https://doi.org/10.1111/ijd.13651

31 Cresnar B, Zakelj-Mavric M. Aspects of the steroid response in fungi. Chem Biol Interact. 2009;178(1-3):303-9. https://doi.org/10.1016/j.cbi.2008.11.002

32 Ledtke C, Rehm SJ, Fraser TG, Shrestha NK, Tan CD, Rodriguez ER et al. Endovascular infections caused by Histoplasma capsulatum: A case series and review of the literature. Arch Pathol Lab. 2012;136(6):640-5. https://doi.org/10.5858/arpa.2011-0050-OA

33 Damasceno LS, Teixeira MM, Barker BM, Almeida MA, Muniz MM, Pizzini CV et al. Novel clinical and dual infection by Histoplasma capsulatum genotypes in HIV patients from Northeastern, Brazil. Sci Rep. 2019;9:11789. https://doi.org/10.1038/s41598-019-48111-6

Creative Commons License
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.

Copyright (c) 1969 Roseli Santos de Freitas-Xavier, Isabel Alves Feitosa Maciel, Vera Lúcia Teixeira de Freitas, Adriana Pardini Vicentini

Downloads

Não há dados estatísticos.